ozempic and other glp-1 drugs The ABC's of GLP-1s: Benefits, Side Effects, Success Stories — Nice Healthcare Doctors explain what really happens

The future of tirzepatide alternatives The weight loss medication pipeline is more active than any other therapeutic area in pharmaceutical development

For 2026, heres what Washington State beneficiaries should know: This is where many people get caught off guard

However, GLP-1 has a very short half-life of about 1.5 minutes and is rapidly suppressed by an enzyme called dipeptidyl peptidase-4 (DPP-4)

They chose Zepbound because emerging data suggested higher average weight loss with tirzepatide

Identifying GLP-1 Non-Responders Early in Treatment Early identification of patients who may not respond adequately to GLP-1 receptor agonist therapy represents a critical step in optimizing obesity treatment pathways

A higher-dose oral (pill) form of semaglutide is also now available for daily use